This study aimed to assess whether stereotactic radiation focusing on individual brain metastases reduces symptom burden and interference with daily functioning compared with hippocampal-avoidance whole brain radiation in patients with 5 to 20 brain metastases.
JAMA (Journal of the American Medical Association) published a clinical update in Research Highlights on 07 Apr 2026.
The item focuses on Treatment for Brain Metastases With Stereotactic Radiation vs Hippocampal-Avoidance Whole Brain Radiation Research Summary.
Review the original article for the full source wording and details.